{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:46:20Z","timestamp":1772545580515,"version":"3.50.1"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,18]]},"DOI":"10.18632\/oncotarget.16237","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T01:56:48Z","timestamp":1489629408000},"page":"48350-48361","source":"Crossref","is-referenced-by-count":16,"title":["High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma"],"prefix":"10.18632","volume":"8","author":[{"given":"Yan","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"},{"name":"Department of Oncology, Nanjing Second Affiliated Hospital of Southeast University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Lin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Dai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Anderson","year":"2011","journal-title":"The New England journal of medicine"},{"key":"2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clml.2011.07.001","article-title":"Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma","volume":"11","author":"Dimopoulos","year":"2011","journal-title":"Clinical lymphoma myeloma and leukemia"},{"key":"3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/cncr.20013","article-title":"Long-term risk of malignant neoplasm associated with gestational glucose intolerance","volume":"100","author":"Dawson","year":"2004","journal-title":"Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/bjc.2012.527","article-title":"PDK1 inhibition is a novel therapeutic target in multiple myeloma","volume":"108","author":"Hata","year":"2013","journal-title":"British journal of cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0609.2010.01466.x","article-title":"High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents","volume":"85","author":"Economopoulos","year":"2010","journal-title":"European journal of haematology"},{"key":"6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0609.2005.00532.x","article-title":"Multiple myeloma in elderly patients: prognostic factors and outcome","volume":"75","author":"Dimopoulos","year":"2005","journal-title":"European journal of haematology"},{"key":"7","first-page":"423","article-title":"Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival","volume":"90","author":"Crowley","year":"2010","journal-title":"Annals of hematology"},{"key":"8","first-page":"715","article-title":"The present and future of serum diagnostic tests for testicular germ cell tumours","volume":"3","author":"Coleman","year":"2016","journal-title":"Nature reviews Urology"},{"key":"9","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood-2015-05-612960","article-title":"How I treat fragile myeloma patients","volume":"126","author":"Palumbo","year":"2015","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.leu.2404413","article-title":"Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis","volume":"21","author":"Escoda","year":"2007","journal-title":"Leukemia"},{"key":"11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hon.2026","article-title":"Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents","volume":"31","author":"Tzenou","year":"2013","journal-title":"Hematological oncology"},{"key":"12","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Gertz","year":"2008","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Russell","year":"2014","journal-title":"Leukemia"},{"key":"14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejca.2009.07.006","article-title":"Improved survival among younger but not among older patients with multiple myeloma in the Netherlands, a population-based study since 1989","volume":"46","author":"Vellenga","year":"2010","journal-title":"European journal of cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Terpos","year":"2015","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Morgan","year":"2005","journal-title":"Journal of clinical oncology"},{"key":"17","first-page":"842","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Salmon","year":"1975","journal-title":"Cancer"},{"key":"18","first-page":"117","article-title":"1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma","volume":"45","author":"Reece","year":"2009","journal-title":"Bone marrow transplantation"},{"key":"19","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood-2007-10-119123","article-title":"An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma","volume":"112","author":"Zhan","year":"2008","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders","volume":"97","author":"Kerndrup","year":"2012","journal-title":"Haematologica"},{"key":"21","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s12032-011-9988-7","article-title":"Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma","volume":"29","author":"Chen","year":"2012","journal-title":"Medical oncology"},{"key":"22","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Attal","year":"2015","journal-title":"Journal of clinical oncology"},{"key":"23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Rajkumar","year":"2009","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Dispenzieri","year":"2014","journal-title":"The Lancet Oncology"},{"key":"25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2013.48.7934","article-title":"International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation","volume":"32","author":"Cavo","year":"2014","journal-title":"Journal of clinical oncology"},{"key":"26","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Beksac","year":"2006","journal-title":"Leukemia"},{"key":"27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10245332.2015.1101969","article-title":"Early mortality in multiple myeloma: Experiences from a single institution","volume":"21","author":"Teng","year":"2016","journal-title":"Hematology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:57:58Z","timestamp":1719104278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":27,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,7,18]]}},"alternative-id":["16237","28418851"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16237","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}